Recent studies have shown that CD24 is overexpressed in various human tumors, including liver cancer, thyroid cancer, and esophageal cancer, where it plays a crucial role in tumor initiation, progression, invasion, and metastasis. The gene discussed is CD24; the disease is thyroid gland carcinoma.